ANTI-CXCR4 ANTIBODIES

The present invention relates to monospecific antibodies against CXCR4 or binding fragments thereof, to the use of such anti-CXCR4 antibodies or binding fragments in treating diseases whose pathogenesis is related to activation of CXCR4, as well as to pharmaceutical compositions comprising such anti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ABBASOVA SVETLANA, KREIMER DAVID, STAUFFER-KELLEHER COLLEEN, KIM ELDAR, MOULON CORINNE, MCALLISTER ANDRES, ULITIN ANDREY, MIKHAYLOV ROMAN, VASILYEVA VIKTORIIA, MIRZABEKOV TAJIB, RIMKEVICH OLGA
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to monospecific antibodies against CXCR4 or binding fragments thereof, to the use of such anti-CXCR4 antibodies or binding fragments in treating diseases whose pathogenesis is related to activation of CXCR4, as well as to pharmaceutical compositions comprising such anti-CXCR4 antibodies or binding fragments. 本发明涉及针对CXCR4的单特异性抗体或其结合片段，涉及此类抗CXCR4抗体或结合片段在治疗发病机理涉及CXCR4的活化的疾病中的用途，以及涉及包含此类抗CXCR4抗体或结合片段的药物组合物。